Lamotrigine-induced neutropenia following two attempts to increase dosage above 50 mg/day with recovery between episodes

Adverse Drug Reactions and Toxicological Reviews

Volumn 21, Issue 3, 2002, Pages 157-159

  Lambert, Olivier ^a   Veyrac, Gwenaëlle ^a   Armand, Christophe ^a   Bourlon, Sandra ^a   Bourin, Michel ^a   Jolliet, Pascale ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; GABAPENTIN; LAMOTRIGINE; OMEPRAZOLE; PHENOBARBITAL; VALPROIC ACID;

AGED; ANAMNESIS; ARTICLE; BLOOD CELL COUNT; CASE REPORT; DOSE RESPONSE; DRUG WITHDRAWAL; DYSPNEA; EPILEPSY; FEMALE; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; NEUTROPENIA; NEUTROPHIL; SIDE EFFECT; THORAX PAIN; WEIGHT REDUCTION;

EID: 0036375172     PISSN: 0964198X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256191     Document Type: Article

References (12)

1. Unexpected or toxic drug reaction assessment (imputation). Actualization of the method used in France
2. Neutropenia associated with omeprazole
3. Neutropenia and thrombocytopenia in three dogs treated with anticonvulsants
4. Side effects of phenobarbital and phenytoin during long-term treatment of epilepsy
5. Meyler's side effects of drugs
6. New antiepileptic drugs: Review on drug interactions
7. Lamotrigine-induced agranulocytosis
8. Agranulocytosis associated with lamotrigine
9. Agranulocytosis associated with lamotrigine
10. Lamotrigine-associated neutropenia in geriatric patient
11. Leucopenia associated with lamotrigine
12. Safety of long-term lamotrigine in epilepsy